Patent Yard Sign in
Expired Canadian patentCanada

Quinuclidine derivatives

CA 2102179 C · Owner: Shimada, Kaoru · Inventors: Kondo, Hiroshi; Shimada, Kaoru; Rosen, Terry J.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of formula (1), wherein R1 is methoxy and R2 is selected from the group consisting of methyl ethyl,isopropyil, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders inflammatory disorders, central nervous system disorders and pain.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 28, 1992 and granted October 27, 1998. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 28, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 28, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 28, 1992
GrantedOctober 27, 1998
Term endedApril 28, 2012
Patent numberCA 2102179 C
Classification (IPC)C07D453/02 +1 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedApril 28, 1992Patent grantedOct 27, 1998Term endedApril 28, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.